After 800 days and nights of hard work, our research and development results have finally taken root, and we are about to share the joyful fruits with researchers all over the world! We are proud to announce that our single B-cell antibody discovery program will be officially delivered this week.

 

At this moment, we would like to express our most sincere gratitude to each and every early adopter who has given us their trust and support. It is your expectation and encouragement that illuminate our way forward like a bright light and make us more determined on the road of research and development. At the same time, we would like to express our heartfelt thanks to every member of our team. It is your wisdom and sweat that have created this brilliant result and enabled us to stand on this brand new starting point.

 

Hypercell®, a future-proof high-throughput single-cell screening platform, helps researchers rapidly capture the mysteries of secreted target single cells in an efficient and cost-effective way. We have crafted an end-to-end solution for antibody discovery that not only integrates the entire process, but also deeply optimizes each experimental step to ensure a smoother and more efficient process. This is designed to speed up antibody development, improve antibody quality and application prospects, and provide stronger support for disease treatment and drug discovery.

 

We look forward to seeing industry colleagues actively trying out our end-to-end solution for antibody discovery, and hope to establish more valuable collaboration opportunities with you!